First Header Logo Second Header Logo

Edward Levine

Concepts (528)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Peritoneal Neoplasms
92
2019
241
19.770
Why?
Hyperthermia, Induced
83
2019
235
15.650
Why?
Chemotherapy, Cancer, Regional Perfusion
53
2019
146
10.910
Why?
Appendiceal Neoplasms
27
2019
81
7.520
Why?
Antineoplastic Combined Chemotherapy Protocols
46
2019
401
7.150
Why?
Adenocarcinoma
48
2019
301
7.150
Why?
Stomach Neoplasms
29
2019
85
4.950
Why?
Breast Neoplasms
42
2021
673
4.840
Why?
Combined Modality Therapy
80
2019
525
4.670
Why?
Sentinel Lymph Node Biopsy
23
2019
69
4.230
Why?
Antineoplastic Agents
28
2018
547
4.060
Why?
Colorectal Neoplasms
20
2018
208
3.780
Why?
Survival Rate
77
2019
796
3.730
Why?
Neoplasm Staging
68
2021
438
3.630
Why?
Neoplasm Recurrence, Local
31
2019
337
3.550
Why?
Middle Aged
180
2021
10913
3.490
Why?
Carcinoma
16
2016
87
3.340
Why?
Humans
248
2021
29396
3.090
Why?
Female
198
2021
18304
3.020
Why?
Adult
131
2021
8503
2.950
Why?
Melanoma
12
2019
148
2.880
Why?
Aged
135
2021
9538
2.810
Why?
Postoperative Complications
26
2018
673
2.690
Why?
Prognosis
67
2019
1367
2.620
Why?
Mitomycin
19
2018
45
2.620
Why?
Retrospective Studies
91
2019
3134
2.600
Why?
Male
154
2019
17930
2.510
Why?
Follow-Up Studies
64
2021
2118
2.370
Why?
Treatment Outcome
68
2021
3119
2.350
Why?
Skin Neoplasms
10
2019
206
2.340
Why?
Adrenal Cortex Neoplasms
16
2019
34
2.280
Why?
Adrenocortical Carcinoma
16
2019
34
2.280
Why?
Lymph Nodes
13
2018
92
2.190
Why?
Aged, 80 and over
69
2021
3733
2.150
Why?
Colonic Neoplasms
9
2016
63
2.120
Why?
Chemotherapy, Adjuvant
31
2019
163
2.110
Why?
Mesothelioma
10
2019
38
2.010
Why?
Gastrectomy
22
2018
65
1.990
Why?
Quality of Life
13
2019
825
1.920
Why?
Liver Neoplasms
13
2018
163
1.910
Why?
Prospective Studies
41
2021
2040
1.800
Why?
Esophageal Neoplasms
6
2014
33
1.760
Why?
Infusions, Parenteral
22
2016
64
1.720
Why?
Mastectomy
13
2019
59
1.590
Why?
Lymphatic Metastasis
28
2018
156
1.590
Why?
Lymph Node Excision
18
2019
89
1.580
Why?
Radiography, Thoracic
2
2019
43
1.330
Why?
Radiopharmaceuticals
9
2010
88
1.330
Why?
Pseudomyxoma Peritonei
7
2014
12
1.320
Why?
Neoplasms
12
2019
620
1.320
Why?
Young Adult
29
2019
2422
1.120
Why?
Mammaplasty
6
2013
27
1.110
Why?
Antibiotics, Antineoplastic
8
2011
62
1.090
Why?
Fluorodeoxyglucose F18
7
2010
56
1.080
Why?
Survival Analysis
30
2017
440
1.070
Why?
Organoplatinum Compounds
5
2013
42
0.990
Why?
Rectal Neoplasms
4
2013
14
0.980
Why?
Jejunal Neoplasms
3
2013
7
0.970
Why?
Adrenalectomy
8
2018
29
0.940
Why?
Disease-Free Survival
22
2018
281
0.890
Why?
Positron-Emission Tomography
6
2010
172
0.880
Why?
Predictive Value of Tests
14
2019
795
0.870
Why?
Mastectomy, Segmental
7
2021
23
0.860
Why?
Duodenal Neoplasms
2
2013
6
0.850
Why?
Peritoneum
6
2013
24
0.840
Why?
Blood Cell Count
2
2019
26
0.830
Why?
Morbidity
10
2017
92
0.820
Why?
Mutation
6
2017
469
0.800
Why?
Carcinoma, Lobular
4
2015
12
0.780
Why?
Adenocarcinoma, Mucinous
3
2014
20
0.780
Why?
Neoplasm Invasiveness
12
2017
189
0.750
Why?
Surgical Wound Infection
3
2019
74
0.740
Why?
Abdominal Neoplasms
3
2014
15
0.740
Why?
Ileal Neoplasms
2
2013
4
0.730
Why?
Hepatectomy
8
2018
66
0.720
Why?
Ovarian Neoplasms
5
2016
88
0.720
Why?
Negative-Pressure Wound Therapy
2
2019
43
0.720
Why?
Pancreatectomy
5
2019
29
0.710
Why?
Gynecology
1
2019
15
0.700
Why?
Obstetrics
1
2019
16
0.700
Why?
Workplace
1
2019
47
0.680
Why?
Liver Function Tests
1
2019
19
0.680
Why?
Burnout, Professional
1
2019
44
0.660
Why?
Esophagectomy
4
2014
15
0.660
Why?
Severity of Illness Index
4
2018
864
0.660
Why?
Adolescent
21
2018
3273
0.660
Why?
Carcinoma, Merkel Cell
2
2009
10
0.660
Why?
Pancreatic Neoplasms
6
2019
131
0.660
Why?
Sarcoma
4
2019
56
0.650
Why?
Rosaniline Dyes
6
2009
19
0.640
Why?
United States
32
2019
3673
0.640
Why?
Enteral Nutrition
2
2015
30
0.620
Why?
Neoplasms, Glandular and Epithelial
3
2016
10
0.610
Why?
Digestive System Neoplasms
1
2017
4
0.590
Why?
Laparotomy
1
2017
32
0.580
Why?
Neoadjuvant Therapy
4
2013
57
0.580
Why?
Cohort Studies
14
2018
1699
0.570
Why?
Coloring Agents
4
2009
30
0.570
Why?
Sensitivity and Specificity
13
2018
533
0.570
Why?
Carboplatin
4
2013
40
0.550
Why?
Gene Expression Profiling
3
2017
321
0.530
Why?
Proportional Hazards Models
13
2017
711
0.530
Why?
Leiomyosarcoma
3
2010
8
0.500
Why?
Length of Stay
7
2017
295
0.500
Why?
Intraoperative Care
7
2015
48
0.500
Why?
Genetic Testing
2
2013
90
0.500
Why?
Angiogenesis Inhibitors
1
2014
34
0.490
Why?
Thalidomide
1
2014
29
0.490
Why?
Registries
9
2018
280
0.480
Why?
Cytological Techniques
2
2011
19
0.480
Why?
Multivariate Analysis
10
2016
638
0.470
Why?
Urinary Bladder Neoplasms
2
2017
179
0.460
Why?
Carcinoma, Intraductal, Noninfiltrating
4
2009
17
0.460
Why?
Adjuvants, Immunologic
2
2011
51
0.450
Why?
Nipples
1
2013
3
0.450
Why?
Breast Diseases
1
2013
4
0.450
Why?
Databases, Factual
11
2018
333
0.440
Why?
Carcinoma, Ductal, Breast
4
2011
28
0.440
Why?
Gene Expression Regulation, Neoplastic
3
2009
249
0.430
Why?
Pancreaticoduodenectomy
2
2019
21
0.430
Why?
Retroperitoneal Neoplasms
2
2019
11
0.420
Why?
Intraoperative Period
6
2011
37
0.420
Why?
BCG Vaccine
1
2011
7
0.410
Why?
Mastectomy, Modified Radical
1
2011
2
0.410
Why?
Genes, BRCA2
2
2011
7
0.410
Why?
Biopsy, Needle
4
2005
89
0.400
Why?
Cisplatin
6
2014
69
0.400
Why?
Adenomatous Polyposis Coli
1
2011
5
0.390
Why?
Secondary Prevention
1
2011
59
0.390
Why?
Lung Neoplasms
5
2017
388
0.390
Why?
Societies, Medical
2
2016
150
0.390
Why?
Adenoma
1
2011
35
0.380
Why?
Medical Oncology
1
2011
74
0.380
Why?
Histocytological Preparation Techniques
1
2010
2
0.380
Why?
Thoracoscopy
1
2010
9
0.370
Why?
Technetium Tc 99m Sulfur Colloid
2
2009
6
0.370
Why?
Colectomy
3
2014
25
0.350
Why?
Nutrition Assessment
2
2014
54
0.350
Why?
Mammography
4
2005
37
0.350
Why?
Tomography, Emission-Computed
3
2005
25
0.350
Why?
Subcutaneous Tissue
1
2009
6
0.340
Why?
Neoplasms, Connective Tissue
1
2009
2
0.340
Why?
Diagnostic Tests, Routine
2
2019
23
0.340
Why?
Risk Factors
14
2018
3588
0.340
Why?
Incidence
8
2018
1124
0.340
Why?
Uterine Neoplasms
1
2009
23
0.340
Why?
Disease Progression
7
2017
574
0.330
Why?
Neuroendocrine Tumors
2
2019
20
0.330
Why?
Yoga
1
2009
41
0.330
Why?
Pregnancy Complications, Neoplastic
2
2011
4
0.320
Why?
Pleural Neoplasms
2
2007
11
0.310
Why?
Catheter Ablation
3
2004
62
0.310
Why?
Radiotherapy, Adjuvant
12
2012
68
0.310
Why?
Anesthesia, Conduction
2
2018
29
0.310
Why?
Fertility Agents, Female
1
2007
8
0.310
Why?
Leuprolide
1
2007
8
0.310
Why?
Frozen Sections
4
2014
18
0.300
Why?
Breast Neoplasms, Male
1
2007
11
0.300
Why?
Microwaves
1
2007
8
0.300
Why?
Biopsy, Fine-Needle
3
2007
50
0.300
Why?
Electrocoagulation
1
2007
12
0.300
Why?
Deoxycytidine
5
2013
63
0.290
Why?
Carcinoma, Squamous Cell
4
2012
143
0.290
Why?
Mental Health
2
2019
104
0.290
Why?
Polymorphism, Genetic
4
2011
196
0.290
Why?
Logistic Models
7
2018
729
0.290
Why?
Health Status
4
2016
370
0.280
Why?
Focal Nodular Hyperplasia
1
2006
3
0.280
Why?
Hemoperitoneum
1
2006
4
0.280
Why?
Patient Readmission
3
2016
106
0.280
Why?
Activities of Daily Living
4
2011
240
0.280
Why?
Child
7
2014
2227
0.280
Why?
Blood Transfusion
2
2017
64
0.280
Why?
Obesity
1
2013
1074
0.270
Why?
Head and Neck Neoplasms
1
2007
118
0.270
Why?
DNA Repair
4
2014
50
0.270
Why?
Nomograms
2
2016
30
0.260
Why?
European Continental Ancestry Group
4
2017
1131
0.260
Why?
Neoplasm Metastasis
8
2019
199
0.260
Why?
North Carolina
8
2015
1426
0.260
Why?
Receptor, erbB-2
2
2014
45
0.260
Why?
Jejunostomy
2
2015
5
0.260
Why?
Preoperative Care
3
2013
110
0.260
Why?
Gallbladder Neoplasms
2
2015
33
0.250
Why?
Pilot Projects
6
2014
483
0.250
Why?
Liposarcoma, Myxoid
1
2004
1
0.250
Why?
Intussusception
1
2004
2
0.250
Why?
Reoperation
5
2017
203
0.250
Why?
Genetic Markers
2
2015
122
0.240
Why?
Genes, erbB-2
1
2003
5
0.240
Why?
Cluster Analysis
2
2015
129
0.240
Why?
Blood Platelets
2
2015
38
0.230
Why?
Prostatic Neoplasms
2
2013
443
0.230
Why?
Ethnic Groups
3
2016
440
0.230
Why?
Parathyroid Neoplasms
1
2003
7
0.230
Why?
Age Factors
8
2017
1116
0.230
Why?
Feasibility Studies
5
2018
268
0.230
Why?
Vascular Surgical Procedures
3
2015
91
0.230
Why?
Reproducibility of Results
5
2015
727
0.230
Why?
Camptothecin
2
2005
48
0.230
Why?
Neutrophils
2
2015
102
0.230
Why?
Breast
1
2003
53
0.230
Why?
Surgical Flaps
3
2013
69
0.220
Why?
Pregnancy
3
2019
823
0.220
Why?
Interferon-alpha
1
2003
69
0.220
Why?
Genes, p53
3
2017
23
0.220
Why?
Cytodiagnosis
3
2011
16
0.220
Why?
DNA, Neoplasm
2
2017
58
0.220
Why?
Clinical Trials as Topic
3
2009
299
0.210
Why?
Injections, Intraperitoneal
5
2014
41
0.210
Why?
Lymphocytes
2
2015
55
0.210
Why?
Biopsy
2
2015
241
0.200
Why?
Hospital Mortality
3
2017
190
0.200
Why?
Consensus
2
2013
70
0.190
Why?
Anus Neoplasms
2
2012
9
0.190
Why?
Pelvis
2
2018
61
0.190
Why?
Necrosis
2
2013
53
0.180
Why?
Radiotherapy Dosage
4
2010
98
0.180
Why?
Randomized Controlled Trials as Topic
3
2013
468
0.180
Why?
Patient Selection
3
2017
257
0.180
Why?
Peritoneal Lavage
1
2019
2
0.180
Why?
Splenectomy
3
2017
19
0.180
Why?
Leadership
1
2019
34
0.170
Why?
Tissue Array Analysis
1
2019
34
0.170
Why?
Immunohistochemistry
4
2008
520
0.170
Why?
Seroma
1
2019
3
0.170
Why?
Laparoscopy
2
2019
169
0.170
Why?
Odds Ratio
7
2015
448
0.170
Why?
Antineoplastic Agents, Hormonal
3
2015
35
0.170
Why?
Myeloid Cells
1
2019
35
0.170
Why?
Surgical Wound Dehiscence
1
2019
11
0.170
Why?
Self Efficacy
1
2019
71
0.170
Why?
Lower Gastrointestinal Tract
1
2018
3
0.170
Why?
Depression
3
2007
386
0.170
Why?
Drug Screening Assays, Antitumor
1
2018
50
0.160
Why?
Time Factors
6
2017
2010
0.160
Why?
Vascular Neoplasms
2
2010
14
0.160
Why?
Cell Proliferation
2
2018
574
0.160
Why?
Digestive System Surgical Procedures
2
2011
20
0.160
Why?
Pain Measurement
2
2018
365
0.160
Why?
Diagnosis, Differential
5
2015
493
0.160
Why?
Intestinal Neoplasms
1
2018
4
0.160
Why?
Vena Cava, Inferior
2
2010
31
0.160
Why?
Practice Guidelines as Topic
2
2013
375
0.160
Why?
Urachus
1
2017
3
0.160
Why?
Appendectomy
1
2018
15
0.160
Why?
Organoids
1
2018
70
0.160
Why?
Intensive Care Units
2
2015
120
0.160
Why?
Risk Assessment
7
2017
1324
0.150
Why?
Disease Management
1
2018
114
0.150
Why?
Hospital Charges
1
2017
13
0.150
Why?
Diaphragm
2
2014
46
0.150
Why?
Crohn Disease
1
2017
25
0.150
Why?
Neoplastic Cells, Circulating
1
2017
23
0.150
Why?
Medicaid
2
2008
83
0.150
Why?
Intestinal Perforation
1
2016
9
0.150
Why?
Cross Infection
1
2017
46
0.150
Why?
Decision Support Techniques
1
2018
104
0.140
Why?
Lymphedema
2
2017
4
0.140
Why?
Vomiting
2
2014
24
0.140
Why?
Models, Biological
1
2018
373
0.140
Why?
Emotions
1
2016
48
0.140
Why?
Nausea
2
2014
49
0.140
Why?
Taxoids
2
2013
48
0.140
Why?
Mitotane
1
2015
2
0.140
Why?
Gastric Stump
1
2015
2
0.140
Why?
Linitis Plastica
1
2015
2
0.140
Why?
African Americans
3
2017
1373
0.140
Why?
Gastroenterostomy
1
2015
2
0.140
Why?
Anastomosis, Roux-en-Y
1
2015
3
0.140
Why?
Biliary Tract Surgical Procedures
1
2015
7
0.130
Why?
Peritoneal Stomata
1
2015
3
0.130
Why?
Bile Ducts
1
2015
18
0.130
Why?
Tumor Cells, Cultured
4
2018
159
0.130
Why?
Forecasting
1
2016
133
0.130
Why?
Bile Duct Neoplasms
1
2015
36
0.130
Why?
Patient Admission
1
2015
53
0.130
Why?
Genetic Predisposition to Disease
3
2014
839
0.130
Why?
Blood Vessels
1
2015
47
0.130
Why?
Anemia
1
2015
55
0.130
Why?
Animals
4
2013
7328
0.130
Why?
Carcinoma, Signet Ring Cell
1
2014
6
0.130
Why?
Skilled Nursing Facilities
1
2014
9
0.130
Why?
Anastomosis, Surgical
2
2015
49
0.130
Why?
Drug Therapy, Combination
2
2013
273
0.130
Why?
Gastrointestinal Stromal Tumors
1
2014
12
0.120
Why?
Protein-Tyrosine Kinases
1
2014
37
0.120
Why?
Abdominal Cavity
1
2014
6
0.120
Why?
Gastrostomy
1
2014
17
0.120
Why?
Thromboembolism
1
2014
30
0.120
Why?
Appendix
1
2014
4
0.120
Why?
Nervous System Diseases
1
2014
37
0.120
Why?
Gastrointestinal Neoplasms
1
2014
32
0.120
Why?
Neoplasm, Residual
3
2016
23
0.120
Why?
Thiosulfates
1
2013
3
0.120
Why?
Granulocyte Colony-Stimulating Factor
1
2013
21
0.120
Why?
Ascites
1
2013
13
0.120
Why?
Urinary Tract
1
2013
21
0.120
Why?
Urologic Diseases
1
2013
28
0.120
Why?
Reconstructive Surgical Procedures
1
2015
190
0.120
Why?
Patient Discharge
1
2014
170
0.110
Why?
Comparative Effectiveness Research
1
2013
23
0.110
Why?
BRCA2 Protein
1
2013
3
0.110
Why?
Tumor Burden
3
2017
60
0.110
Why?
BRCA1 Protein
1
2013
10
0.110
Why?
Genomics
1
2013
82
0.110
Why?
Genotype
2
2012
735
0.110
Why?
Anthracyclines
1
2013
51
0.110
Why?
Fatty Acids
1
2013
94
0.110
Why?
Maximum Tolerated Dose
2
2012
56
0.110
Why?
Body Mass Index
3
2016
868
0.100
Why?
Tissue Expansion Devices
1
2011
10
0.100
Why?
Diet
1
2014
356
0.100
Why?
Immunotherapy, Active
1
2011
6
0.100
Why?
Clinical Trials, Phase III as Topic
1
2011
27
0.100
Why?
Clinical Competence
1
2014
308
0.100
Why?
Genes, BRCA1
1
2011
9
0.100
Why?
Evidence-Based Medicine
1
2013
208
0.100
Why?
Magnetic Resonance Imaging
2
2018
1221
0.100
Why?
Immunoenzyme Techniques
3
2015
46
0.100
Why?
Polymorphism, Single Nucleotide
3
2014
1080
0.100
Why?
Chi-Square Distribution
3
2009
293
0.100
Why?
Heterozygote
1
2011
52
0.100
Why?
Oligonucleotide Array Sequence Analysis
1
2012
155
0.100
Why?
Diabetes Mellitus
1
2014
376
0.100
Why?
Case-Control Studies
5
2014
861
0.100
Why?
Sleep
1
2012
88
0.100
Why?
Nucleic Acid Amplification Techniques
1
2011
8
0.100
Why?
Pancreatitis
1
2011
18
0.100
Why?
Organizational Objectives
1
2010
22
0.100
Why?
Poverty
2
2008
99
0.090
Why?
Cooperative Behavior
1
2010
73
0.090
Why?
Phenotype
1
2012
633
0.090
Why?
Smoking
2
2017
440
0.090
Why?
Patient Satisfaction
1
2011
223
0.090
Why?
Research Design
1
2012
287
0.090
Why?
Cost-Benefit Analysis
1
2010
160
0.090
Why?
Tomography, X-Ray Computed
3
2018
871
0.090
Why?
Fluorouracil
4
2012
73
0.090
Why?
Medical Records
4
2012
68
0.090
Why?
Equipment Design
2
2007
167
0.090
Why?
Protein Biosynthesis
1
2009
47
0.080
Why?
Hysterectomy
1
2009
37
0.080
Why?
Colonoscopy
1
2008
41
0.080
Why?
Multifactorial Inheritance
1
2008
21
0.080
Why?
Glutathione S-Transferase pi
1
2008
6
0.080
Why?
Aryl Hydrocarbon Hydroxylases
1
2008
6
0.080
Why?
Glutathione Transferase
1
2008
18
0.080
Why?
Telomere
1
2008
10
0.080
Why?
Models, Genetic
1
2008
95
0.080
Why?
Comorbidity
3
2017
548
0.080
Why?
Radiation Tolerance
1
2008
22
0.080
Why?
Cross-Sectional Studies
1
2012
1376
0.080
Why?
Ascitic Fluid
1
2007
7
0.080
Why?
Radiation Injuries
1
2008
68
0.080
Why?
Leg
1
2007
57
0.080
Why?
Paclitaxel
3
2013
51
0.080
Why?
Neck
1
2007
26
0.080
Why?
NAD
1
2007
25
0.070
Why?
Neoplasm Proteins
3
2017
141
0.070
Why?
Hematologic Diseases
1
2007
23
0.070
Why?
Cell Death
1
2007
72
0.070
Why?
Health Surveys
1
2007
191
0.070
Why?
Sequence Analysis, DNA
2
2017
139
0.070
Why?
Neutropenia
2
2008
23
0.070
Why?
Patient Participation
1
2007
63
0.070
Why?
Health Promotion
1
2009
220
0.070
Why?
Carcinoembryonic Antigen
1
2006
7
0.070
Why?
Exercise
1
2011
596
0.070
Why?
False Negative Reactions
1
2006
21
0.070
Why?
Keratins
1
2006
37
0.070
Why?
Rupture
1
2006
29
0.070
Why?
Dose-Response Relationship, Drug
2
2012
641
0.070
Why?
Axilla
2
2003
15
0.070
Why?
Fluorescent Dyes
1
2006
45
0.070
Why?
Telomerase
1
2006
21
0.070
Why?
Survival
1
2006
13
0.070
Why?
Continental Population Groups
1
2007
221
0.070
Why?
Endosonography
1
2006
56
0.070
Why?
Suture Techniques
1
2006
56
0.070
Why?
International Agencies
2
2017
6
0.060
Why?
Drug Administration Schedule
3
2012
247
0.060
Why?
Hemangioma, Cavernous
1
2004
3
0.060
Why?
Nevus
1
2004
15
0.060
Why?
Malignant Carcinoid Syndrome
1
2003
1
0.060
Why?
Gene Amplification
1
2003
9
0.060
Why?
Anoikis
1
2003
2
0.060
Why?
Tropomyosin
1
2003
3
0.060
Why?
In Situ Hybridization, Fluorescence
1
2003
38
0.060
Why?
Monitoring, Intraoperative
1
2004
39
0.060
Why?
Hypercalcemia
1
2003
8
0.060
Why?
Hyperplasia
1
2003
38
0.060
Why?
Carcinoma, Neuroendocrine
1
2003
13
0.060
Why?
Regression Analysis
1
2004
274
0.060
Why?
Massage
1
2003
11
0.060
Why?
Preoperative Period
2
2014
32
0.060
Why?
Flow Cytometry
1
2003
172
0.060
Why?
Drosophila Proteins
1
2003
43
0.060
Why?
Cell Biology
1
2002
2
0.060
Why?
Specimen Handling
1
2002
31
0.050
Why?
Cryopreservation
1
2002
54
0.050
Why?
Recombinant Proteins
1
2003
249
0.050
Why?
Health Services Accessibility
2
2019
231
0.050
Why?
Postoperative Care
2
2018
72
0.050
Why?
Polymerase Chain Reaction
3
2008
173
0.050
Why?
Image Processing, Computer-Assisted
1
2003
242
0.050
Why?
Tissue Fixation
1
2019
10
0.040
Why?
Paraffin Embedding
1
2019
10
0.040
Why?
Remission Induction
2
2010
78
0.040
Why?
Formaldehyde
1
2019
11
0.040
Why?
Pancreatic Diseases
1
2019
16
0.040
Why?
Single-Blind Method
2
2011
166
0.040
Why?
Reference Values
1
2018
224
0.040
Why?
Intestine, Small
1
2018
35
0.040
Why?
Cell Survival
1
2018
274
0.040
Why?
ROC Curve
1
2018
149
0.040
Why?
Pathology, Molecular
1
2017
16
0.040
Why?
Intention to Treat Analysis
1
2017
23
0.040
Why?
Genes, erbB-1
1
2017
15
0.040
Why?
Clone Cells
1
2017
36
0.040
Why?
Genes, Neoplasm
1
2017
18
0.040
Why?
Genes, ras
1
2017
26
0.040
Why?
DNA-Binding Proteins
2
2011
143
0.040
Why?
Tumor Suppressor Protein p53
1
2017
71
0.040
Why?
Protein Kinase Inhibitors
1
2017
77
0.040
Why?
Recovery of Function
1
2018
190
0.040
Why?
Diarrhea
2
2008
56
0.040
Why?
Heart Diseases
1
2017
99
0.040
Why?
Neoplastic Stem Cells
1
2017
90
0.040
Why?
Pancreatic Fistula
1
2016
3
0.030
Why?
Postoperative Period
1
2016
92
0.030
Why?
Abdomen
1
2016
43
0.030
Why?
Chemoprevention
1
2015
9
0.030
Why?
Neoplasms, Second Primary
1
2015
16
0.030
Why?
Platelet Count
1
2015
21
0.030
Why?
Lymphocyte Count
1
2015
23
0.030
Why?
Hydrocortisone
1
2015
61
0.030
Why?
Stomach
1
2015
16
0.030
Why?
Shock, Septic
1
2015
29
0.030
Why?
Lung Diseases
1
2015
45
0.030
Why?
Signal Transduction
1
2019
669
0.030
Why?
Blood Loss, Surgical
1
2015
45
0.030
Why?
Cause of Death
1
2015
221
0.030
Why?
Spleen
1
2015
82
0.030
Why?
Colon
1
2015
56
0.030
Why?
Pancreas
1
2015
79
0.030
Why?
Ultrasonography
1
2017
348
0.030
Why?
beta Carotene
1
2014
5
0.030
Why?
Analysis of Variance
1
2015
454
0.030
Why?
Folic Acid Deficiency
1
2014
2
0.030
Why?
Chemoembolization, Therapeutic
1
2014
9
0.030
Why?
Folic Acid
1
2014
12
0.030
Why?
Malnutrition
1
2014
17
0.030
Why?
Micronutrients
1
2014
15
0.030
Why?
Serum Albumin
1
2014
53
0.030
Why?
Pneumonia
1
2014
62
0.030
Why?
Omentum
1
2014
26
0.030
Why?
Perfusion
1
2014
64
0.030
Why?
Thrombosis
1
2014
60
0.030
Why?
Prevalence
1
2017
910
0.030
Why?
Receptors, Estrogen
1
2014
90
0.030
Why?
Zinc
1
2014
32
0.030
Why?
Respiratory Insufficiency
1
2014
61
0.030
Why?
Arrhythmias, Cardiac
1
2014
81
0.030
Why?
Ovariectomy
1
2014
147
0.030
Why?
Energy Intake
1
2014
120
0.030
Why?
Cyclophosphamide
1
2013
25
0.030
Why?
American Recovery and Reinvestment Act
1
2013
1
0.030
Why?
Societies, Scientific
1
2013
12
0.030
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2013
5
0.030
Why?
National Cancer Institute (U.S.)
1
2013
18
0.030
Why?
Research Support as Topic
1
2013
25
0.030
Why?
Doxorubicin
1
2013
56
0.030
Why?
Carcinoma, Non-Small-Cell Lung
1
2013
94
0.030
Why?
Liver
1
2015
464
0.030
Why?
Surgery, Plastic
1
2012
26
0.030
Why?
Europe
1
2012
78
0.030
Why?
Physician's Role
1
2012
38
0.030
Why?
Multicenter Studies as Topic
1
2012
93
0.030
Why?
Physical Therapy Modalities
1
2011
60
0.020
Why?
Cell Cycle Proteins
1
2011
48
0.020
Why?
Nuclear Proteins
1
2011
72
0.020
Why?
Platinum Compounds
1
2010
3
0.020
Why?
Cell Line, Tumor
1
2013
684
0.020
Why?
Contrast Media
1
2010
124
0.020
Why?
Patient Compliance
1
2011
212
0.020
Why?
Temperature
1
2010
57
0.020
Why?
Patient Education as Topic
1
2011
252
0.020
Why?
Sex Factors
1
2011
632
0.020
Why?
Colonic Polyps
1
2008
16
0.020
Why?
Polymorphism, Single-Stranded Conformational
1
2008
5
0.020
Why?
Infusions, Intravenous
1
2008
85
0.020
Why?
Dose-Response Relationship, Radiation
1
2008
76
0.020
Why?
DNA Primers
1
2008
87
0.020
Why?
Radiation Dosage
1
2008
72
0.020
Why?
Patient Care
1
2008
33
0.020
Why?
Probability
1
2008
150
0.020
Why?
Confidence Intervals
1
2008
141
0.020
Why?
Administration, Oral
1
2008
169
0.020
Why?
Gender Identity
1
2007
18
0.020
Why?
SEER Program
1
2007
33
0.020
Why?
Alleles
1
2008
251
0.020
Why?
National Institutes of Health (U.S.)
1
2007
29
0.020
Why?
Base Sequence
1
2008
242
0.020
Why?
Leucovorin
1
2007
20
0.020
Why?
Drainage
1
2007
49
0.020
Why?
Sex Distribution
1
2007
187
0.020
Why?
Age Distribution
1
2007
199
0.020
Why?
Observer Variation
1
2006
96
0.020
Why?
Vacuum
1
2006
25
0.020
Why?
Thrombocytopenia
1
2005
32
0.020
Why?
Gastrointestinal Diseases
1
2005
38
0.020
Why?
Fatigue
1
2005
69
0.020
Why?
Blood Vessel Prosthesis Implantation
1
2005
70
0.020
Why?
Wound Healing
1
2006
186
0.020
Why?
S100 Proteins
1
2004
18
0.010
Why?
Polymorphism, Restriction Fragment Length
1
2003
9
0.010
Why?
Antigens, Neoplasm
1
2004
44
0.010
Why?
Protein Isoforms
1
2003
56
0.010
Why?
Genes, Tumor Suppressor
1
2003
36
0.010
Why?
Stereotaxic Techniques
1
2003
23
0.010
Why?
Cell Transformation, Neoplastic
1
2003
57
0.010
Why?
Patient Care Planning
1
2004
53
0.010
Why?
Tumor Suppressor Proteins
1
2003
72
0.010
Why?
Down-Regulation
1
2003
143
0.010
Why?
Tamoxifen
1
2002
48
0.010
Why?
RNA, Messenger
1
2003
520
0.010
Why?
Gene Expression Regulation
1
2003
481
0.010
Why?
Levine's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (528)
Explore
_
Co-Authors (49)
Explore
_
Similar People (50)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_